Arbutus Biopharma Corporation Common Stock
ABUS Real Time Price USDRecent trades of ABUS by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by ABUS's directors and management
Government lobbying spending instances
Estimated quarterly lobbying spending
New patents grants
-
Patent Title: Non-liposomal systems for nucleic acid delivery Oct. 29, 2024
-
Patent Title: Substituted 1,1′-biphenyl compounds, analogues thereof, and methods using same Sep. 10, 2024
-
Patent Title: Targeted compositions Jul. 23, 2024
-
Patent Title: Lipids and compositions for the delivery of therapeutics Jul. 23, 2024
-
Patent Title: Non-liposomal systems for nucleic acid delivery Jul. 16, 2024
-
Patent Title: Lipid compositions Jul. 02, 2024
-
Patent Title: Lipid formulations for delivery of therapeutic agents Jun. 25, 2024
-
Patent Title: Methods for ameliorating infusion reactions Feb. 20, 2024
-
Patent Title: Targeted nucleic acid conjugate compositions Feb. 13, 2024
-
Patent Title: Lipid formulations for delivery of therapeutic agents Oct. 17, 2023
-
Patent Title: Non-liposomal systems for nucleic acid delivery Aug. 08, 2023
-
Patent Title: Lipids and compositions for the delivery of therapeutics Aug. 01, 2023
-
Patent Title: Substituted 2-pyridone tricyclic compounds, analogues thereof, and methods using same Jul. 18, 2023
-
Patent Title: Substituted tetrahydrocyclopenta[c]pyrroles, substituted dihydropyrrolizines, analogues thereof, and methods using same Jan. 31, 2023
-
Patent Title: Methods for preparing substituted pyridinone-containing tricyclic compounds Nov. 22, 2022
-
Patent Title: Lipid formulations for delivery of therapeutic agents Sep. 20, 2022
-
Patent Title: Targeted compositions Aug. 30, 2022
-
Patent Title: Lipid containing formulations Aug. 23, 2022
-
Patent Title: Trialkyl cationic lipids and methods of use thereof Jul. 26, 2022
-
Patent Title: Methods for ameliorating infusion reactions Jun. 07, 2022
-
Patent Title: Liposomal apparatus and manufacturing methods May. 03, 2022
-
Patent Title: Liposomal apparatus and manufacturing methods Apr. 12, 2022
-
Patent Title: Compositions and methods for delivering messenger rna Dec. 07, 2021
-
Patent Title: Lipid formulations for nucleic acid delivery Oct. 12, 2021
-
Patent Title: Substituted 2,3-dihydro-1h-indene analogs and methods using same Sep. 28, 2021
-
Patent Title: Substituted dihydroindene-4-carboxamides and analogs thereof, and methods using same Aug. 24, 2021
-
Patent Title: Lipids and compositions for the delivery of therapeutics Aug. 03, 2021
-
Patent Title: Substituted pyridinone-containing trycyclic compounds, and methods using same May. 25, 2021
-
Patent Title: Substituted chromane-8-carboxamide compounds and analogues thereof, and methods using same May. 11, 2021
-
Patent Title: Lipid compositions Mar. 23, 2021
-
Patent Title: Lipids and compositions for the delivery of therapeutics Nov. 17, 2020
-
Patent Title: Lipids and compositions for the delivery of therapeutics Nov. 03, 2020
-
Patent Title: Substituted pyridinone-containing trycyclic compounds, and methods using same Nov. 03, 2020
-
Patent Title: Trialkyl cationic lipids and methods of use thereof Feb. 18, 2020
-
Patent Title: Substituted 1-hydroxy-pyridin-2(1h)-ones, and methods of making and using same Feb. 04, 2020
-
Patent Title: Lipid compositions Oct. 29, 2019
-
Patent Title: Compositions and methods for silencing hepatitis b virus gene expression Sep. 17, 2019
-
Patent Title: Substituted 2-n-hydroxy-1,3-dioxo-1,2,3,4-tetrahydronaphthyridines, and methods of making and using same Jul. 23, 2019
-
Patent Title: Lipids and compositions for the delivery of therapeutics Nov. 06, 2018
-
Patent Title: Cyclic cationic lipids and methods of use Sep. 18, 2018
-
Patent Title: Methods for increasing efficacy of lipid formulated sirna Aug. 21, 2018
-
Patent Title: Site-specific delivery of nucleic acids by combining targeting ligands with endosomolytic components Feb. 20, 2018
-
Patent Title: Targeting lipids Nov. 14, 2017
-
Patent Title: Lipids and compositions for the delivery of therapeutics Sep. 19, 2017
-
Patent Title: Lipids and compositions for the delivery of therapeutics Jul. 18, 2017
-
Patent Title: Lipid compositions Jul. 04, 2017
-
Patent Title: Compositions for nucleic acid delivery Jun. 27, 2017
-
Patent Title: Lipids and compositions for the delivery of therapeutics Jun. 20, 2017
-
Patent Title: Lipid containing formulations May. 30, 2017
-
Patent Title: In vitro release assay for liposome encapsulated vincristine May. 02, 2017
Federal grants, loans, and purchases
Estimated quarterly amount awarded from public contracts
Number of mentions of ABUS in WallStreetBets Daily Discussion
Recent insights relating to ABUS
Recent picks made for ABUS stock on CNBC
ETFs with the largest estimated holdings in ABUS
|
Shareholder
|
Shares Held
|
|---|
* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view ABUS Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.